APA (7th ed.) Citation

Lu, T., Zhang, J., Xu-Monette, Z. Y., & Young, K. H. (2023). The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 12(1), 1. https://doi.org/10.1186/s40164-023-00432-z

Chicago Style (17th ed.) Citation

Lu, Tingxun, Jie Zhang, Zijun Y. Xu-Monette, and Ken H. Young. "The Progress of Novel Strategies on Immune-based Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma." Experimental Hematology & Oncology 12, no. 1 (2023): 1. https://doi.org/10.1186/s40164-023-00432-z.

MLA (9th ed.) Citation

Lu, Tingxun, et al. "The Progress of Novel Strategies on Immune-based Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma." Experimental Hematology & Oncology, vol. 12, no. 1, 2023, p. 1, https://doi.org/10.1186/s40164-023-00432-z.